Benelux: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Benelux

In 2023, the Benelux medicaments containing insulin market increased by X% to $X, rising for the second consecutive year after two years of decline. Overall, consumption showed a relatively flat trend pattern. The level of consumption peaked at $X in 2019; however, from 2020 to 2023, consumption remained at a lower figure.

Medicaments Containing Insulin Production in Benelux

In value terms, medicaments containing insulin production expanded modestly to $X in 2023 estimated in export price. In general, production, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 with an increase of X% against the previous year. As a result, production attained the peak level of $X. From 2018 to 2023, production growth remained at a lower figure.

Medicaments Containing Insulin Exports

Exports in Benelux

Medicaments containing insulin exports fell dramatically to X tons in 2023, waning by X% compared with 2022 figures. In general, exports showed a dramatic descent. The growth pace was the most rapid in 2021 with an increase of X% against the previous year. Over the period under review, the exports hit record highs at X tons in 2017; however, from 2018 to 2023, the exports stood at a somewhat lower figure.

In value terms, medicaments containing insulin exports contracted dramatically to $X in 2023. Over the period under review, exports, however, showed a significant expansion. The pace of growth was the most pronounced in 2021 when exports increased by X%. As a result, the exports attained the peak of $X. From 2022 to 2023, the growth of the exports remained at a somewhat lower figure.

Exports by Country

The Netherlands dominates exports structure, reaching X tons, which was near X% of total exports in 2023. It was distantly followed by Belgium (X kg), making up an X% share of total exports.

From 2014 to 2023, average annual rates of growth with regard to medicaments containing insulin exports from the Netherlands stood at X%. Belgium (X%) illustrated a downward trend over the same period. The Netherlands (X p.p.) significantly strengthened its position in terms of the total exports, while Belgium saw its share reduced by X% from 2014 to 2023, respectively.

In value terms, the Netherlands ($X) remains the largest medicaments containing insulin supplier in Benelux, comprising X% of total exports. The second position in the ranking was held by Belgium ($X), with a X% share of total exports.

From 2014 to 2023, the average annual rate of growth in terms of value in the Netherlands stood at X%.

Export Prices by Country

In 2023, the export price in Benelux amounted to $X per ton, rising by X% against the previous year. Over the period under review, the export price saw significant growth. The most prominent rate of growth was recorded in 2015 an increase of X% against the previous year. The level of export peaked in 2023 and is expected to retain growth in years to come.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while Belgium amounted to $X per ton.

From 2014 to 2023, the most notable rate of growth in terms of prices was attained by the Netherlands (X%).

Medicaments Containing Insulin Imports

Imports in Benelux

After three years of decline, purchases abroad of medicaments containing insulin but not antibiotics increased by X% to X kg in 2023. Over the period under review, imports, however, recorded a deep slump. The most prominent rate of growth was recorded in 2019 with an increase of X% against the previous year. As a result, imports attained the peak of X tons. From 2020 to 2023, the growth of imports remained at a lower figure.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2023. In general, imports enjoyed a resilient expansion. The pace of growth was the most pronounced in 2019 when imports increased by X%. As a result, imports attained the peak of $X. From 2020 to 2023, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2023, the Netherlands (X kg) represented the largest importer of medicaments containing insulin but not antibiotics, creating X% of total imports. It was distantly followed by Luxembourg (X kg), making up a X% share of total imports. Belgium (X kg) followed a long way behind the leaders.

Imports into the Netherlands decreased at an average annual rate of X% from 2012 to 2023. At the same time, Luxembourg (X.0%) displayed positive paces of growth. Moreover, Luxembourg emerged as the fastest-growing importer imported in Benelux, with a CAGR of X.0% from 2012-2023. By contrast, Belgium (X%) illustrated a downward trend over the same period. Luxembourg (X p.p.) and Belgium (X p.p.) significantly strengthened its position in terms of the total imports, while the Netherlands saw its share reduced by X% from 2012 to 2023, respectively.

In value terms, the largest medicaments containing insulin importing markets in Benelux were the Netherlands ($X), Belgium ($X) and Luxembourg ($X), with a combined X% share of total imports.

Luxembourg, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2023, the import price in Benelux amounted to $X per ton, growing by X% against the previous year. In general, the import price saw a significant increase. The pace of growth was the most pronounced in 2021 when the import price increased by X%. The level of import peaked in 2023 and is likely to continue growth in the near future.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Belgium ($X,400 per ton), while Luxembourg ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Belgium (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform